Variant report
Variant | esv2445879 |
---|---|
Chromosome Location | chr5:29068601-29071153 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:6)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:6 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ARID3A | chr5:29070987-29071060 | K562 | blood: | n/a | n/a |
2 | FOXA1 | chr5:29068731-29069068 | HepG2 | liver: | n/a | n/a |
3 | JUN | chr5:29070574-29070705 | K562 | blood: | n/a | n/a |
4 | MXI1 | chr5:29070547-29070574 | K562 | blood: | n/a | n/a |
5 | NFYB | chr5:29068912-29069112 | GM12878 | blood: | n/a | n/a |
6 | POLR2A | chr5:29069125-29069157 | K562 | blood: | n/a | n/a |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:29059482..29062466-chr5:29065874..29068673,2 | MCF-7 | breast: |
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-CDH6-3 | chr5:29066381-29070363 | NR_109948 |
2 | lnc-CDH6-3 | chr5:29066381-29070363 | ENSG00000249322 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000252601 | TF binding region |
CBFB | miRNA target sites |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs74454748 | chr5:29068619-29068620 | Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
2 | rs575479840 | chr5:29068621-29068622 | Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
3 | rs569109135 | chr5:29068630-29068631 | Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
4 | rs55882562 | chr5:29068639-29068640 | Active TSS Enhancers | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs557895172 | chr5:29068649-29068650 | Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
6 | rs656260 | chr5:29068698-29068699 | Active TSS Enhancers | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs528392971 | chr5:29068717-29068718 | Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
8 | rs577615663 | chr5:29068719-29068720 | Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
9 | rs540272571 | chr5:29068768-29068769 | Active TSS Enhancers | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs185693995 | chr5:29068774-29068775 | Active TSS Enhancers | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs74682341 | chr5:29068786-29068787 | Active TSS Enhancers | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs550369541 | chr5:29068829-29068830 | Enhancers Active TSS | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs520652 | chr5:29068889-29068890 | Enhancers Active TSS | TF binding regionlncRNA | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs544662217 | chr5:29068952-29068953 | Enhancers Active TSS | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs552349411 | chr5:29068963-29068964 | Enhancers Active TSS | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs553844282 | chr5:29068981-29068982 | Enhancers Active TSS | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs556477787 | chr5:29069015-29069016 | Enhancers Active TSS Flanking Active TSS | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs570848245 | chr5:29069036-29069037 | Enhancers Active TSS Flanking Active TSS | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs534943535 | chr5:29069054-29069055 | Enhancers Active TSS Flanking Active TSS | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs658439 | chr5:29069162-29069163 | Enhancers Active TSS Flanking Active TSS | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs523336 | chr5:29069169-29069170 | Enhancers Active TSS Flanking Active TSS | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs535963245 | chr5:29069183-29069184 | Enhancers Active TSS Flanking Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
23 | rs557210908 | chr5:29069221-29069222 | Active TSS Flanking Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
24 | rs556918172 | chr5:29069237-29069238 | Active TSS Flanking Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
25 | rs2932806 | chr5:29069260-29069261 | Active TSS Flanking Active TSS Enhancers | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs546068506 | chr5:29069269-29069270 | Active TSS Flanking Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
27 | rs557975681 | chr5:29069306-29069307 | Active TSS Flanking Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
28 | rs373692692 | chr5:29069317-29069318 | Active TSS Flanking Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
29 | rs114605869 | chr5:29069386-29069387 | Active TSS Flanking Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
30 | rs116525614 | chr5:29069479-29069480 | Active TSS Flanking Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
31 | rs189824986 | chr5:29069499-29069500 | Active TSS Flanking Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
32 | rs149476616 | chr5:29069627-29069628 | Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
33 | rs150936605 | chr5:29069631-29069632 | Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
34 | rs561746735 | chr5:29069637-29069638 | Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
35 | rs545280379 | chr5:29069657-29069658 | Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
36 | rs528915196 | chr5:29069658-29069659 | Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
37 | rs544173104 | chr5:29069659-29069660 | Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
38 | rs555536699 | chr5:29069665-29069666 | Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
39 | rs200348998 | chr5:29069669-29069670 | Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
40 | rs251070 | chr5:29069673-29069674 | Active TSS Enhancers | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs370501733 | chr5:29069674-29069675 | Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
42 | rs188517173 | chr5:29069675-29069676 | Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
43 | rs552359947 | chr5:29069691-29069692 | Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
44 | rs570661996 | chr5:29069702-29069703 | Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
45 | rs200934195 | chr5:29069723-29069724 | Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
46 | rs528778714 | chr5:29069795-29069796 | Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
47 | rs73747184 | chr5:29069819-29069820 | Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
48 | rs544296774 | chr5:29069845-29069846 | Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
49 | rs546941115 | chr5:29069854-29069855 | Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
50 | rs568724365 | chr5:29069872-29069873 | Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Kartagener syndrome | 16639409 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Cervical squamous cell carcinoma | 21590768 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Liposarcoma | 21253554 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Cervical cancer | 21062161 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cervical cancer | 18559093 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Multiple myeloma | 17550852 | CNVD |
prenatal diagnosis | 22389664 | CNVD |
Bladder cancer | 21909424 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Breast cancer | 21858162 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Cancer | 16751803 | CNVD |
Breast cancer | 16608533 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 18172304 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Intellectual disability | 22102821 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21183584 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 17603634 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Compulsive disorder | 18923513 | CNVD |
Epilepsy | 18923513 | CNVD |
Prader-willi syndrome | 18923513 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Glioma | 20126413 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Breast cancer | 22032731 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 20409316 | CNVD |
Medulloblastoma | 19270706 | CNVD |
Breast cancer | 19553991 | CNVD |
Lung cancer | 19553991 | CNVD |
Melanoma | 19553991 | CNVD |
Ovarian cancer | 19553991 | CNVD |
Prostate cancer | 19553991 | CNVD |
Non-small cell lung cancer | 17156491 | CNVD |
Breast cancer | 17133270 | CNVD |
Bipolar disorder | 19114987 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:29068400-29068800 | Active TSS | Pancreatic Islets | Pancreatic Islet |
2 | chr5:29068400-29069200 | Enhancers | Pancreas | Pancrea |
3 | chr5:29068400-29069200 | Enhancers | HepG2 | liver |
4 | chr5:29068400-29070200 | Active TSS | Rectal Mucosa Donor 29 | rectum |
5 | chr5:29068600-29069000 | Active TSS | Rectal Mucosa Donor 31 | rectum |
6 | chr5:29068600-29069000 | Active TSS | Stomach Mucosa | stomach |
7 | chr5:29069000-29069200 | Flanking Active TSS | Stomach Mucosa | stomach |
8 | chr5:29069000-29069400 | Active TSS | Rectal Smooth Muscle | rectum |
9 | chr5:29069000-29069600 | Flanking Active TSS | Rectal Mucosa Donor 31 | rectum |
10 | chr5:29069200-29069600 | Enhancers | Stomach Mucosa | stomach |
11 | chr5:29069600-29070800 | Enhancers | Rectal Mucosa Donor 31 | rectum |